search Result

Smart metering in India needs acceleration: CareEdge

The government’s smart metering initiative presents a $20-25 billion opportunity and is backed by an estimated investment of Rs 1.25 trillion, comprising Rs 950 million in debt and 25% equity. Read more

US imposes 26% reciprocal tariff on Indian Exports; CareEdge

While the 26% may seem restrictive, it is lower than tariffs imposed on the competitors—Vietnam (46%), Bangladesh (37%), China (34%), Taiwan and Indonesia (32%), and Pakistan (29%)—giving India a relative edge in key sectors.Read more

Indian defence industry to grow around 20% from FY24-FY29: CareEdge

India’s defence exports include a diverse array of products such as aircraft, naval systems, missile technology, and military hardware.Read more

India's solar equipment sector set for Rs 1 trillion investment: CareEdge

To protect and empower domestic manufacturers, the Indian government has implemented a Basic Customs Duty of 25% on solar cells and 40% on modules imported from China since April 2022. Read more

The Rise of India’s Construction Equipment Industry

Driven by increased government spending, rapid urbanization, technological advancements, and the 'Make in India' initiative, the RAHSTA (road) ahead for the construction equipment (CE) industry is bright with full of possibilities and opportunitiesRead more

RAHSTA Expo 2024 concludes to a grand success

Smart Manufacturing & Enterprises (SME) and Equipment India (EI) host construction equipment (CE) industry leaders to discuss the future of CE industry. The 10th India Construction Festival (ICF) 2024 awards over 75 companies from infrastructure industry. Read more

Budget 2024-25: Analysis of Budget impact on MSMEs

The budget places special attention on MSMEs and labour-intensive manufacturing, introducing a new assessment model for MSME credit by public sector banks based on digital footprints rather than only on assets and turnover criteria. Read more

Commercial vehicles to decline 3-6%; two-wheelers to grow 7-9% in FY25 India

Both segments have experienced significant transformations and faced unique challenges over the past few years, particularly in the wake of the COVID-19 pandemic.Read more

Indian pharmaceutical industry to expand by 9%; surpass $70 billion by FY27

Between FY13 and FY18, Indian pharma companies faced severe regulatory challenges that adversely impacted their operations and ability to launch new products in regulated markets. Read more

Increased scrutiny by US FDA: A boon or bane Indian pharmaceutical sector

Even with the surge in USFDA-approved manufacturing sites in India, the proportion of Official Action Initiated (OAI) observations by the USFDA has stayed consistent at 10% of total inspections in CY23. Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016